Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication

Published:2024-08 Issue: Volume:228 Page:105946
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Baliga-Gil Agnieszka,Soszynska-Jozwiak Marta,Ruszkowska Agnieszka^ORCID,Szczesniak Izabela,Kierzek Ryszard^ORCID,Ciechanowska Maria,Trybus Magdalena,Jackowiak Paulina,Peterson Jake M.^ORCID,Moss Walter N.,Kierzek Elzbieta^ORCID

Funder

European Regional Development Fund

Narodowe Centrum Nauki

Publisher

Elsevier BV

Reference62 articles.

1. Chapter 1: History and development of nucleotide analogues in nucleic acids drugs, In;Agrawal;RSC Drug Discovery Series,2019

2. A map of the SARS-CoV-2 RNA Structurome;Andrews;NAR Genomics Bioinforma,2021

3. COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs;Bartoli;Intern. Emerg. Med.,2021

4. Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19;Biernacki;J. Enzym. Inhib. Med. Chem.,2023

5. The architecture of the SARS-CoV-2 RNA genome inside virion;Cao;Nat. Commun.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP